CURE BEST

Brand Owner (click to sort) Address Description
CUREBEST SYSMEX CORPORATION 1-5-1, Wakinohama-kaigandori, Chuo-ku, Kobe, Hyogo 651-0073 Japan CURE BEST;Providing medical diagnostic services, testing and information in the field of cancer diagnosis; medical analyses, in particular, gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; gene, protein and cell analysis for medical diagnostic purposes; clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; and medical services, in particular laboratory testing services in the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; providing information regarding medical diagnostic testing results and disease conditions for diagnostic purposes;medical testing and research services of genes, proteins and cells, and reporting of results for medical and scientific research purposes; providing laboratory research services in the field of gene expression; gene expression analysis service for others for medical and scientific research purposes; medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; providing medical and scientific research information regarding diagnostic testing results and disease conditions; scientific research for medical purposes in the area of cancerous diseases; medical research in the field of cancer diagnosis and cancer treatment; providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; and analytic and diagnostic services for medical and scientific research purposes in the analysis of biological sample for forecasting and predicting a recurrence of cancer;
CUREBEST SYSMEX CORPORATION 1-5-1, Wakinohama-kaigandori, Chuo-ku, Kobe, Hyogo 651-0073 Japan CURE BEST;Providing medical and scientific testing and research information in the field of genetics; Providing information regarding medical diagnostic testing results and disease conditions for medical diagnosis purposes; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of genetics; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of cancer diagnosis; Gene, protein and cell analysis for medical diagnostic testing purposes; Medical analyses, in particular gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; Clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; Medical services, in particular, laboratory testing services comprising the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer;Medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; Medical testing and research services in the field of genes, proteins and cells, and reporting of results for medical and scientific research purposes; Providing medical and scientific research information regarding diagnostic testing results and disease conditions; Providing laboratory research services in the field of gene expression; Gene expression analysis service for others in the nature of genetic testing for medical and scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of cancer diagnosis and cancer treatment; Providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; Analytic and diagnostic testing services for medical and scientific research purposes, namely, the analysis of biological samples for forecasting and predicting a recurrence of cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A one-component or single component cure system for a polysiloxane product is provided. The cure system includes a siloxane reagent that has an unsaturated organic functional group for reacting with a crosslinking reagent. The cure system also has a crosslinking reagent that has a silicon hydride group for crosslinking with the unsaturated organic group of the siloxane reagent. Either the unsaturated functional group of the siloxane reagent, the silicon hydride group of the crosslinking reagent, or both are sterically hindered. The siloxane reagent and the sterically hindered silicon hydride crosslinking reagent are mixed together in the presence of a catalyst reagent to form the one-component cure system. Methods of making the polysiloxane product are also provided.